Digital Health Technology Consulting

Jean-Philippe Couderc, PhD, MBA
JPC NewHealth LLC delivers expert consulting in digital health technology validation and regulatory submission strategy. Founded and led by Jean‑Philippe Couderc, PhD, MBA, a globally recognized leader in digital health innovation, the company brings decades of experience at the intersection of technology development, clinical science, and regulatory affairs.
Dr. Couderc has collaborated extensively with the U.S. Food and Drug Administration (FDA) and leading academic institutions worldwide. His unique perspective ensures that your innovations are not only scientifically sound but also aligned with regulatory expectations—making JPC NewHealth LLC a trusted partner in shaping the future of digital medicine.
Our Consulting Services
At JPC NewHealth, we offer a range of consulting services tailored to the digital health industry. Our expertise includes strategic planning, regulatory compliance, digital health product development, clinical validation, and more.


David Borkholder, PhD
"I have worked with JP Couderc as a colleague doing research, and tapping into his deep experience while at a startup company to help define clinical research design. His knowledge of regulatory science allowed us to move from concept to a fully executable clinical protocol tailored for FDA submission. He helped our team identify the right endpoints, patient population, and data strategy to ensure our study would meet regulatory expectations. JP's ability to bridge scientific rigor with practical industry insight gave us a clear path toward FDA clearance and confidence in the quality of our evidence. His professionalism, responsiveness, and commitment to our project made him an invaluable partner throughout the process."

Mike Totterman, MBA
I had the pleasure of working closely with Jean-Philippe Couderc during the early and high-growth phases of iCardiac Technologies, a digital health company at the forefront of cardiac safety and ECG analytics. Jean-Philippe brought a rare combination of scientific depth, entrepreneurial agility, and regulatory acumen to the table, making him an invaluable partner as we navigated clinical validation. His ability to bridge the academic and business worlds is unmatched. He not only co-developed the core algorithms that powered our technology but also advised our leadership team on matters ranging from strategic positioning to investor communications. His guidance consistently aligned innovation with regulatory requirements and real-world clinical impact.

Gill Tsouri, PhD
I had the fortunate pleasure of collaborating with Prof' Couderc over the past 10 years on joint RIT-UoR research projects. His vast experience in managing clinical studies and navigating healthcare regulatory frameworks helped tremendously in validating and advancing technologies developed in my lab.
.png)